Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
23 hedge funds and large institutions have $27.4M invested in Alpine Immune Sciences Inc in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 22 → 23 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
43% less capital invested
Capital invested by funds: $48M → $27.4M (-$20.5M)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hikari Power
Tokyo,
Japan
|
+$607K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$350K |
| 3 |
Morgan Stanley
New York
|
+$32.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.58K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$8.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$678K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$533K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$167K |
| 4 |
Renaissance Technologies
New York
|
-$133K |
| 5 |
Millennium Management
New York
|
-$68K |
ALPN Hedge Fund Activity: Q4 2018 in Review
23 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q4 2018, worth a combined $27.4M — down 43% from $48M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ALPN positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Hikari Power, opening a new position worth an estimated $607K. The largest seller was Deerfield Management, cutting an estimated $678K.
- 23 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q4 2018, up from 22 in Q3 2018.
- Funds reported $27.4M of Alpine Immune Sciences Inc stock for Q4 2018, down 43% quarter-over-quarter.
- 3 funds opened new Alpine Immune Sciences Inc positions in Q4 2018 and 2 closed out, a net change of +1 holder.
- The largest Alpine Immune Sciences Inc buyer in Q4 2018 was Hikari Power, an estimated $607K added.
- The largest Alpine Immune Sciences Inc seller in Q4 2018 was Deerfield Management, an estimated $678K sold.
Based on aggregated 13F filings for Q4 2018.